ArticleJournal of clinical immunology2022

Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations.

Pilar Blanco Lobo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.